Bank of New York Mellon Corp Trims Stock Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Bank of New York Mellon Corp reduced its stake in Henry Schein, Inc. (NASDAQ:HSIC) by 3.2% during the 4th quarter, Holdings Channel reports. The institutional investor owned 870,921 shares of the company’s stock after selling 28,569 shares during the period. Bank of New York Mellon Corp’s holdings in Henry Schein were worth $60,268,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Versant Capital Management Inc increased its stake in Henry Schein by 274.6% during the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock worth $32,000 after purchasing an additional 335 shares during the period. Venturi Wealth Management LLC increased its stake in Henry Schein by 3,347.1% during the fourth quarter. Venturi Wealth Management LLC now owns 586 shares of the company’s stock worth $41,000 after purchasing an additional 569 shares during the period. Quent Capital LLC increased its stake in Henry Schein by 91.2% during the fourth quarter. Quent Capital LLC now owns 677 shares of the company’s stock worth $47,000 after purchasing an additional 323 shares during the period. City State Bank purchased a new stake in Henry Schein during the fourth quarter worth about $55,000. Finally, Farther Finance Advisors LLC increased its stake in Henry Schein by 58.9% during the third quarter. Farther Finance Advisors LLC now owns 933 shares of the company’s stock worth $68,000 after purchasing an additional 346 shares during the period. 96.62% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of analysts have issued reports on the stock. UBS Group cut their price target on shares of Henry Schein from $83.00 to $80.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 26th. Mizuho assumed coverage on shares of Henry Schein in a research note on Wednesday, December 4th. They set a “neutral” rating and a $75.00 price target on the stock. Jefferies Financial Group boosted their price target on shares of Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research note on Thursday, January 23rd. Barrington Research restated an “outperform” rating and set a $90.00 target price on shares of Henry Schein in a research note on Wednesday, February 26th. Finally, Bank of America upgraded shares of Henry Schein from an “underperform” rating to a “buy” rating and upped their target price for the stock from $69.00 to $84.00 in a research note on Monday, January 6th. Six equities research analysts have rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $81.10.

Henry Schein Stock Performance

Shares of HSIC opened at $70.31 on Wednesday. The stock has a 50 day moving average price of $74.41 and a 200 day moving average price of $72.51. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. The company has a market capitalization of $8.73 billion, a price-to-earnings ratio of 28.93, a price-to-earnings-growth ratio of 2.13 and a beta of 0.91. Henry Schein, Inc. has a 52-week low of $63.67 and a 52-week high of $82.49.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.04). The business had revenue of $3.19 billion during the quarter, compared to analyst estimates of $3.25 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business’s revenue for the quarter was up 5.8% compared to the same quarter last year. During the same period last year, the company earned $0.66 earnings per share. Research analysts predict that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.